| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2021 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 1,376 | $26.83 | $36,918.08 | -2.7% | |
| Jan 6, 2021 | Dube Eric M57 | Chief Executive Officer | Sell | 6,876 | $26.83 | $184,483.08 | -3.7% | |
| Dec 15, 2020 | Aselage Steve80 | Director | Sell | 5,549 | $26.02 | $144,384.98 | -2.7% | |
| Dec 2, 2020 | Aselage Steve80 | Director | Sell | 7,891 | $23.43 | $184,849.04 | -3.8% | |
| Nov 25, 2020 | Clague Laura64 | Chief Financial Officer | Sell | 7,500 | $23.29 | $174,675.00 | -14.9% | |
| Nov 16, 2020 | Clague Laura64 | Chief Financial Officer | Sell | 7,500 | $23.98 | $179,812.50 | -27.8% | |
| Nov 16, 2020 | Rote William E.58 | Senior Vice President, R&D | Sell | 2,500 | $23.96 | $59,900.00 | -9.4% | |
| Nov 16, 2020 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 2,500 | $23.98 | $59,950.00 | -9.0% | |
| Nov 13, 2020 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 2,500 | $23.62 | $59,045.50 | -8.2% | |
| Nov 13, 2020 | Rote William E.58 | Senior Vice President, R&D | Sell | 2,500 | $23.62 | $59,056.00 | -8.6% |